Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07075731 · ClinicalTrials.gov registry record
Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
A clinical trial of Cancer Screening and Transgender, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT07075731: Recruiting study of Cancer Screening and Transgender, sponsored by University of Minnesota.
NCT07075731 is a study of Cancer Screening and Transgender that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 40 participants, below the 677-participant average among 4 other Cancer Screening trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07075731, a study of Cancer Screening and Transgender, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future
Primary Outcome
Describe the rates of cervical cancer screening and endometrial sampling in TGD individuals undergoing hysterectomy in the MHealth Fairview System between January 2014-June 2024.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
Minnesota
- University of Minnesota - Minneota
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-06-30 |
| Est. Completion | 2027-06-30 |
What NCT07075731 shows while recruiting
NCT07075731 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 677-participant average among 4 other Cancer Screening trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT07075731 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07075731 about?
NCT07075731 is a clinical study titled "Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy". This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hyster...
What is the current status of trial NCT07075731?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-06-30. Estimated completion is 2027-06-30.
What conditions does trial NCT07075731 study?
This clinical trial studies the following conditions: Cancer Screening, Transgender, Gender Diverse Populations.
What interventions are being tested in trial NCT07075731?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT07075731?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07075731 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
RECRUITING · NA
-
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
RECRUITING · NA
-
Participatory Approaches to Qualitative Research (PAQ): Comparing Two Approaches to Patient, Public and Clinician Involvement in Qualitative Research
RECRUITING · NA
-
Discussing Stopping Cancer Screening and Prognosis With Older Adults
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI